VANVAN NGUYEN: Open Payments
NPI 1336737360 · HENDERSON, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,892 in 70 payments from 17 companies in 2025. Trend: 2023 $1,176 · 2024 $1,300 · 2025 $1,892
Food & beverage: $1,892
| Company | Payments | Amount |
|---|---|---|
| Intra-Sana Laboratories | 10 | $386 |
| Novo Nordisk Inc | 11 | $352 |
| AstraZeneca Pharmaceuticals LP | 13 | $292 |
| Dexcom, Inc. | 9 | $201 |
| Axsome Therapeutics, Inc. | 1 | $112 |
| Phathom Pharmaceuticals, Inc. | 1 | $108 |
| Amgen Inc. | 5 | $91 |
| Exact Sciences Corporation | 4 | $78 |
| Lilly USA, LLC | 4 | $65 |
| Tactile Systems Technology Inc | 3 | $46 |
Products named: RELTONE 200 MG, Ozempic, DEXCOM G7 GSS (161), Symbravo, AIRSUPRA, VOQUEZNA, FARXIGA, BREZTRI.
Industry payments across NV — which companies pay providers there.
